66 related articles for article (PubMed ID: 18829559)
1. Use of Biomarker Data and Relative Potencies of Mutagenic Metabolites to Support Derivation of Cancer Unit Risk Values for 1,3-Butadiene from Rodent Tumor Data.
Kirman CR; Hays SM
Toxics; 2022 Jul; 10(7):. PubMed ID: 35878299
[TBL] [Abstract][Full Text] [Related]
2. 1,3-Butadiene: a ubiquitous environmental mutagen and its associations with diseases.
Chen WQ; Zhang XY
Genes Environ; 2022 Jan; 44(1):3. PubMed ID: 35012685
[TBL] [Abstract][Full Text] [Related]
3. Internal Doses of Glycidol in Children and Estimation of Associated Cancer Risk.
Aasa J; Vryonidis E; Abramsson-Zetterberg L; Törnqvist M
Toxics; 2019 Feb; 7(1):. PubMed ID: 30717263
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Novel N-(4-Hydroxybenzyl)valine Hemoglobin Adducts in Human Blood.
Degner A; Carlsson H; Karlsson I; Eriksson J; Pujari SS; Tretyakova NY; Törnqvist M
Chem Res Toxicol; 2018 Dec; 31(12):1305-1314. PubMed ID: 30375232
[TBL] [Abstract][Full Text] [Related]
5. Parallelogram based approach for in vivo dose estimation of genotoxic metabolites in humans with relevance to reduction of animal experiments.
Motwani HV; Frostne C; Törnqvist M
Sci Rep; 2017 Dec; 7(1):17560. PubMed ID: 29242644
[TBL] [Abstract][Full Text] [Related]
6. Non‑infective occupational risk factors for hepatocellular carcinoma: A review (Review).
Ledda C; Loreto C; Zammit C; Marconi A; Fago L; Matera S; Costanzo V; Fuccio Sanzà G; Palmucci S; Ferrante M; Costa C; Fenga C; Biondi A; Pomara C; Rapisarda V
Mol Med Rep; 2017 Feb; 15(2):511-533. PubMed ID: 28000892
[TBL] [Abstract][Full Text] [Related]
7. Interaction of benzo[a]pyrene diol epoxide isomers with human serum albumin: Site specific characterisation of adducts and associated kinetics.
Motwani HV; Westberg E; Törnqvist M
Sci Rep; 2016 Nov; 6():36243. PubMed ID: 27805056
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma and the risk of occupational exposure.
Rapisarda V; Loreto C; Malaguarnera M; Ardiri A; Proiti M; Rigano G; Frazzetto E; Ruggeri MI; Malaguarnera G; Bertino N; Malaguarnera M; Catania VE; Di Carlo I; Toro A; Bertino E; Mangano D; Bertino G
World J Hepatol; 2016 May; 8(13):573-90. PubMed ID: 27168870
[TBL] [Abstract][Full Text] [Related]
9. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.
Pianalto KM; Hartman JH; Boysen G; Miller GP
Toxicol Lett; 2013 Nov; 223(2):221-7. PubMed ID: 24021170
[TBL] [Abstract][Full Text] [Related]
10. Risk of hepatocellular carcinoma in workers exposed to chemicals.
Uccello M; Malaguarnera G; Corriere T; Biondi A; Basile F; Malaguarnera M
Hepat Mon; 2012 Oct; 12(10 HCC):e5943. PubMed ID: 23162599
[TBL] [Abstract][Full Text] [Related]
11. Alcohol dehydrogenase- and rat liver cytosol-dependent bioactivation of 1-chloro-2-hydroxy-3-butene to 1-chloro-3-buten-2-one, a bifunctional alkylating agent.
Elfarra AA; Zhang XY
Chem Res Toxicol; 2012 Nov; 25(11):2600-7. PubMed ID: 23110628
[TBL] [Abstract][Full Text] [Related]
12. 1,3-Butadiene: Biomarkers and application to risk assessment.
Swenberg JA; Bordeerat NK; Boysen G; Carro S; Georgieva NI; Nakamura J; Troutman JM; Upton PB; Albertini RJ; Vacek PM; Walker VE; Sram RJ; Goggin M; Tretyakova N
Chem Biol Interact; 2011 Jun; 192(1-2):150-4. PubMed ID: 20974116
[TBL] [Abstract][Full Text] [Related]
13. Exposure-response of 1,2:3,4-diepoxybutane-specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene.
Georgieva NI; Boysen G; Bordeerat N; Walker VE; Swenberg JA
Toxicol Sci; 2010 Jun; 115(2):322-9. PubMed ID: 20176624
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cancer tests of 1,3-butadiene using internal dose, genotoxic potency, and a multiplicative risk model.
Fred C; Törnqvist M; Granath F
Cancer Res; 2008 Oct; 68(19):8014-21. PubMed ID: 18829559
[TBL] [Abstract][Full Text] [Related]
15. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
Motwani HV; Törnqvist M
Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
[TBL] [Abstract][Full Text] [Related]
16. Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol.
Powley MW; Li Y; Upton PB; Walker VE; Swenberg JA
Carcinogenesis; 2005 Sep; 26(9):1573-80. PubMed ID: 15888494
[TBL] [Abstract][Full Text] [Related]
17. The importance of 3,4-epoxy-1,2-butanediol and hydroxymethylvinyl ketone in 3-butene-1,2-diol associated mutagenicity.
Powley MW; Walker VE; Li Y; Upton PB; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):182-90. PubMed ID: 17349618
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
